Disclosures

Royalties received from Arthrex, Inc.; Organogenesis
Speaker for Arthrex, Inc.; MedShape, Inc.; Regentis; Samumed, Inc.; Vericel; ZimmerBiomet
Paid Consultant for Aesculap; Arthrex, Inc.; Cartiheal; Ceterix Orthopaedics; Exactech; Moximed, Inc.; Organogenesis; Samumed, Inc.; TRX Orthopedics, Inc.; Vericel; ZimmerBiomet; Zipline Medical
Stock received from MedShape, Inc.; OrthoRegenerative Technologies, Inc.
Support received from Active Implants; Arthrex, Inc.; Ceterix Orthopaedics; Fidia Pharma; Histogenics; Moximed, Inc.; Novartis, Inc.; Organogenesis, Inc.; Vericel; ZimmerBiomet. Funds were submitted to the Orthopaedic Research Foundation or Cartilage Research Foundation
Royalties or support received from Springer Science+Business Media; Thieme Medical Publishers
Editorial or Governing board of American Journal of Sports Medicine; Cartilage; Clinical Orthopaedics and Related Research; Journal of Clinical Orthopaedics and Trauma; Journal of Knee Surgery; Knee Surgery, Sports, Traumatology, Arthroscopy; Biologic Orthopaedic Journal; The Knee
Board of Directors member for AANA Learning Center Committee; International Cartilage Repair Society; International Patellofemoral Study Group; ISAKOS Knee Arthoplasty and Alternatives Committee; Patellofemoral Foundation